Position in BMY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$342,954
-$42,294 QoQ
Shares Held
5,952
-6.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,784
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. BMY ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
118,345 | $15,207,332 | |
| 2 | JNJ |
Johnson & Johnson
|
58,033 | $14,738,640 | |
| 3 | AMGN |
Amgen Inc
|
28,143 | $10,191,142 | |
| 4 | LLY |
ELI LILLY & Co
|
1,816 | $2,178,165 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,971 | $1,638,755 | |
| 6 | ABBV |
AbbVie Inc.
|
5,799 | $1,459,260 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
5,952 | $342,954 | |
| 8 | NVO |
Novo Nordisk A S
|
4,826 | $231,358 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $342,954 | 5,952 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $385,248 | 6,352 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $403,147 | 7,474 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $337,438 | 7,482 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $346,341 | 7,482 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $386,249 | 6,333 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $358,194 | 6,333 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $327,669 | 6,333 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $248,349 | 5,980 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $324,295 | 5,980 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $306,833 | 5,980 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $352,651 | 6,076 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $363,875 | 5,690 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $396,869 | 5,726 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $410,043 | 5,699 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $399,028 | 5,613 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $432,201 | 5,613 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $418,169 | 5,726 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $345,793 | 5,546 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $400,758 | 6,773 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $452,571 | 6,773 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $435,533 | 6,899 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $439,544 | 7,086 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $408,223 | 6,771 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $394,900 | 6,716 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $595,358 | 10,681 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||